Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.91−0.13 (-12.46%)
Close on Nov 13, 2026Market cap $47.03MP/E –Yield –
Talphera total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Talphera's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $25.15M in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $5.36M | -61.1% |
| FY2021 | Dec 31, 2021 | $13.80M | -36.9% |
| FY2020 | Dec 31, 2020 | $21.88M | -13.0% |
| FY2019 | Dec 31, 2019 | $25.15M | +109.7% |
| FY2018 | Dec 31, 2018 | $11.99M | -37.2% |
| FY2017 | Dec 31, 2017 | $19.10M | -11.4% |
| FY2016 | Dec 31, 2016 | $21.55M | +3.0% |
| FY2015 | Dec 31, 2015 | $20.92M | -15.9% |
| FY2014 | Dec 31, 2014 | $24.87M | +73.2% |
| FY2013 | Dec 31, 2013 | $14.36M | -10.1% |
| FY2012 | Dec 31, 2012 | $15.97M | -16.3% |
| FY2011 | Dec 31, 2011 | $19.08M | +266.6% |
| FY2010 | Dec 31, 2010 | $5.20M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $3.32M | -72.0% |
| Q4 FY2022 | Dec 31, 2022 | $5.36M | -61.1% |
| Q3 FY2022 | Sep 30, 2022 | $7.89M | -49.9% |
| Q2 FY2022 | Jun 30, 2022 | $9.89M | -45.5% |
| Q1 FY2022 | Mar 31, 2022 | $11.85M | -40.8% |
| Q4 FY2021 | Dec 31, 2021 | $13.80M | -36.9% |
| Q3 FY2021 | Sep 30, 2021 | $15.73M | -33.7% |
| Q2 FY2021 | Jun 30, 2021 | $18.14M | -30.3% |
| Q1 FY2021 | Mar 31, 2021 | $20.01M | -22.3% |
| Q4 FY2020 | Dec 31, 2020 | $21.88M | -13.0% |
| Q3 FY2020 | Sep 30, 2020 | $23.71M | -1.2% |
| Q2 FY2020 | Jun 30, 2020 | $26.03M | +9.5% |
| Q1 FY2020 | Mar 31, 2020 | $25.74M | +156.8% |
| Q4 FY2019 | Dec 31, 2019 | $25.15M | +109.7% |
| Q3 FY2019 | Sep 30, 2019 | $24.01M | +73.0% |
| Q2 FY2019 | Jun 30, 2019 | $23.77M | +51.6% |
| Q1 FY2019 | Mar 31, 2019 | $10.03M | -42.4% |
| Q4 FY2018 | Dec 31, 2018 | $11.99M | -37.2% |
| Q3 FY2018 | Sep 30, 2018 | $13.87M | -38.1% |
| Q2 FY2018 | Jun 30, 2018 | $15.68M | -28.8% |
| Q1 FY2018 | Mar 31, 2018 | $17.41M | -19.5% |
| Q4 FY2017 | Dec 31, 2017 | $19.10M | -11.4% |
| Q3 FY2017 | Sep 30, 2017 | $22.41M | – |
| Q2 FY2017 | Jun 30, 2017 | $22.02M | – |
| Q1 FY2017 | Mar 31, 2017 | $21.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.55M | – |
See a number that looks wrong?